Gayer Charles K 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Dec 17, 2024
Insider Transaction Report
Form 4
Gayer Charles K
Vice President and CCO
Transactions
- Tax Payment
Common Stock
2024-12-14$7.53/sh−8,251$62,130→ 300,057 total
Footnotes (1)
- [F1]Represents shares withheld by the Issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the Reporting Person.